Research is being conducted on the role of bacteriocin-producing probiotic lactic acid bacteria in controlling dysbiosis of the gut microbiota. Studies suggest that probiotics may have a key role in disease prevention and treatment, and may also be used to target the microbial-metabolic axis in managing certain disorders. The gut microbiota is being explored as a potential target for therapies to treat various conditions, including irritable bowel syndrome and metabolic disorders.